A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India

Clinical trial NCT05329259 · COMPLETED

Trial details

NCT number: NCT05329259
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2022-10-06
Primary completion: 2022-11-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.